eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin May 9, 2023 eFFECTOR Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update Read More »
NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Portfolio News / By Karina Tin May 8, 2023 NGM Bio Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin for the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) and Bile Acid Malabsorption (BAM) at Digestive Disease Week 2023 Read More »
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Portfolio News / By Karina Tin May 8, 2023 ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates Read More »
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin May 8, 2023 Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress Read More »
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data Portfolio News / By Karina Tin May 4, 2023 NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data Read More »
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting Portfolio News / By Karina Tin May 3, 2023 Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting Read More »
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201 Portfolio News / By Karina Tin May 2, 2023 Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201 Read More »
Neurona Therapeutics Presents Updated Data from the NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2023 Annual Meeting Portfolio News / By Karina Tin April 24, 2023 Neurona Therapeutics Presents Updated Data from the NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2023 Annual Meeting Read More »
Circle Pharma’s First-in-Class Orally Bioavailable Macrocyclic Cyclin A/B Inhibitors Highlighted in Poster Presentations at American Association for Cancer Research Annual Meeting Portfolio News / By Karina Tin April 19, 2023 Circle Pharma’s First-in-Class Orally Bioavailable Macrocyclic Cyclin A/B Inhibitors Highlighted in Poster Presentations at American Association for Cancer Research Annual Meeting Read More »
ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting Portfolio News / By Karina Tin April 18, 2023 ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting Read More »
